No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review

URN to cite this document:: urn:nbn:de:bvb:355-epub-296265
DOI to cite this document:: 10.5283/epub.29626

Zuuren, Esther J. van ; Apfelbacher, Christian J. ; Fedorowicz, Zbys ; Jupiter, Aldrin ; Matterne, Uwe ; Weisshaar, Elke

Preview

PDF
(314kB)

Date of publication of this fulltext: 19 Mar 2014 13:17

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background The most important symptom as well as one of the major diagnostic criteria for eczema is itch. Although oral antihistamines continue to be prescribed for people with eczema, it is unclear if they are effective and safe in relieving itch and skin lesions. We sought to evaluate the available evidence on effectiveness of oral antihistamines (H1 antagonists) as monotherapy in children and ...